FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 AG SELF TEST 2CT

MDR report key: 19751832 · Received July 16, 2024

Report

Report Number
1221359-2024-00494
Event Type
Malfunction
Date Received
July 16, 2024
Date of Event
June 28, 2024
Report Date
August 26, 2024
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
UDI-DI
00811877011408
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 220606 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160/ LOT: 220606, TEST BASE PART NUMBER 195-430WJR/ LOT: 217803. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 220606 SHOWED THAT THE COMPLAINT RATE IS (B)(4)%. ABBOTT DIAGNOSTICS SCARBOROUGH, INC. WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE.

Additional Manufacturer Narrative · 0

THE REMAINDER OF THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.

Description of Event or Problem · 0

THE CONSUMER REPORTED FALSE NEGATIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST KIT FOR FIVE (5) TESTS PERFORMED ON VARIOUS DATES. THIS MFR. REPORT ADDRESSES TEST TWO (2) OF FIVE (5). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2024 ON A NASAL SAMPLE. REPEAT TESTING WAS PERFORMED ONCE MORE ON (B)(6) 2024, TWICE ON (B)(6) 2024, AND TWICE ON (B)(6) 2024 WHICH GENERATED FOUR (4) NEGATIVE RESULTS, AND ONE (1) POSITIVE RESULT ON (B)(6) 2024.THE CONSUMER INDICATED THEY WERE EXPERIENCING SYMPTOMS SUCH AS SORE THROAT AND RUNNY NOSE. ON (B)(6) 2024, THE CUSTOMER WAS PRESCRIBED PAXLOVID BY THEIR HEALTHCARE PROVIDER. THE CONSUMER CONFIRMED THERE WAS NO DEATH OR SERIOUS INJURY. NO ADDITIONAL INFORMATION, INCLUDING DELAY OR IMPACT IN THE PATIENT'S TREATMENT, WAS PROVIDED.

Description of Event or Problem · 0

THE CONSUMER REPORTED FALSE NEGATIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST KIT FOR FIVE (5) TESTS PERFORMED ON VARIOUS DATES. THIS MFR. REPORT ADDRESSES TEST TWO (2) OF FIVE (5). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2024 ON A NASAL SAMPLE. REPEAT TESTING WAS PERFORMED ONCE MORE ON (B)(6) 2024, TWICE ON (B)(6) 2024, AND TWICE ON (B)(6) 2024 WHICH GENERATED FOUR (4) NEGATIVE RESULTS, AND ONE (1) POSITIVE RESULT ON (B)(6) 2024.THE CONSUMER INDICATED THEY WERE EXPERIENCING SYMPTOMS SUCH AS SORE THROAT AND RUNNY NOSE. ON (B)(6) 2024, THE CUSTOMER WAS PRESCRIBED PAXLOVID BY THEIR HEALTHCARE PROVIDER. THE CONSUMER CONFIRMED THERE WAS NO DEATH OR SERIOUS INJURY. NO ADDITIONAL INFORMATION, INCLUDING DELAY OR IMPACT IN THE PATIENT'S TREATMENT, WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
739012 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 220606 00811877011408

Patients

Seq Age Sex Outcome Treatment
1 82 YR Female